Indoximod
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Indoximod, covering 2020-04-03 to 2026-04-03. Get the full timeline:
Most recent: Clinical Trial Update: Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer [Phase 1, Phase 2]